Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer.
Leboulleux S, Bournaud C, Chougnet CN, Zerdoud S, Al Ghuzlan A, Catargi B, Do Cao C, Kelly A, Barge ML, Lacroix L, Dygai I, Vera P, Rusu D, Schneegans O, Benisvy D, Klein M, Roux J, Eberle MC, Bastie D, Nascimento C, Giraudet AL, Le Moullec N, Bardet S, Drui D, Roudaut N, Godbert Y, Morel O, Drutel A, Lamartina L, Schvartz C, Velayoudom FL, Schlumberger MJ, Leenhardt L, Borget I.
N Engl J Med. 2022 Mar 10;386(10):923-932. doi: 10.1056/NEJMoa2111953.
PMID:35263518
Direct Labeling of Gold Nanoparticles with Iodine-131 for Tumor Radionuclide Therapy.
Zhu M, Zhao L, Lu X.
Int J Nanomedicine. 2024 Nov 13;19:11805-11818. doi: 10.2147/IJN.S484976. eCollection 2024.
PMID:39553458
Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α.
Dekempeneer Y, Massa S, Santens F, Navarro L, Berdal M, Lucero MM, Pombo Antunes AR, Lahoutte T, Van Ginderachter JA, Devoogdt N, D'Huyvetter M.
Phase I study of [(131)I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol.
Thivat E, Rouanet J, Auzeloux P, Sas N, Jouberton E, Levesque S, Billoux T, Mansard S, Molnar I, Chanchou M, Fois G, Maigne L, Chezal JM, Miot-Noirault E, D'Incan M, Durando X, Cachin F.
Iodine-131 radioembolization boosts the immune activation enhanced by icaritin/resiquimod in hepatocellular carcinoma.
Li X, Qian Y, Lu X, Xu M, He S, Zhang J, Song S.
J Control Release. 2025 Feb 10;378:849-863. doi: 10.1016/j.jconrel.2024.12.064. Epub 2024 Dec 31.
PMID:39730069
Hybrid Protein Nano-Reactors Enable Simultaneous Increments of Tumor Oxygenation and Iodine-131 Delivery for Enhanced Radionuclide Therapy.
Chen J, Liang C, Song X, Yi X, Yang K, Feng L, Liu Z.
Small. 2019 Nov;15(46):e1903628. doi: 10.1002/smll.201903628. Epub 2019 Oct 2.
PMID:31577387
Correlation analysis between the quantitative parameters of iodine-131 single-photon emission computed tomography-computed tomography thyroid bed uptake and the efficacy of radioactive iodine adjuvant therapy for papillary thyroid cancer.
Mao Y, Lin R, Wang Y, Yu J.
Quant Imaging Med Surg. 2024 May 1;14(5):3665-3675. doi: 10.21037/qims-23-1723. Epub 2024 Apr 26.
PMID:38720856
Smart (131) I-Labeled Self-Illuminating Photosensitizers for Deep Tumor Therapy.
Guo J, Feng K, Wu W, Ruan Y, Liu H, Han X, Shao G, Sun X.
Angew Chem Int Ed Engl. 2021 Sep 27;60(40):21884-21889. doi: 10.1002/anie.202107231. Epub 2021 Aug 26.